Welcome to the inaugural episode of Healthcare Elsewhere! We’re very excited to be publishing the show live for all the listeners out there, so without further ado here’s the first episode…
In today’s episode you’ll hear from Holly Huber who was diagnosed with Multiple Sclerosis nearly 10 years ago that got so bad that she couldn’t walk, drive a car, or live independently without relying on others for assistance.
After trying every treatment available in the US from multiple injections per day to ‘black box’ medications (high risk medications who’s potential side effects can be lethal) she began to look into the alternative options, and through an immense amount or research she ended up in Costa Rica for a treatment that’s not yet approved by the FDA.
Tune in to this episode to hear all about Holly’s journey to Costa Rica, the various lab and treatment options she considered and how she found success with a state-of-the-art treatment that isn’t yet fully approved involving stem cells from both herself and adult cells obtained from umbilical cords.
In This Episode, You’ll Learn
- How Holly went from being unable to hold an intelligent conversation to walking and driving a car in only 3 months
- Why all the ‘usual’ prescribed methods for curing Holly’s MS didn’t work (and the actions she took next)
- The research that lead Holly to choose a treatment facility in San Jose, Costa Rica and why that was the best
- The importance of transparency in any of the doctors, clinics or hospitals you consider for treatment
- Holly Huber – Hollyhuber@gmail.com – 858 829 2490
- On Twitter @stemcellsuccess
- On Facebook.com – Holly Huber
- CellMedicine.com – Holly’s Clinic in Costa Rica (Now Panama)
The Onwards Medical Breakthrough
In today’s Onwards Medical Breakthrough, there was a test at the University of Edinburgh which successfully took the old, aged thymus (that is a gland that helps the immune system operate properly) of a mouse and through treatment they were able to restore it to a youthful state using regenerative medicine techniques.
This finding will surely have a big impact on regenerative medicine, and could certainly influence the way we administer treatments for corrective, regenerative patients in the future. Learn more about the team’s findings in the article posted here.